Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if FHTX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
24 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
103 filers reported a long position in FHTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Flagship Pioneering, LLC | $61.8M | 12.7M | Unchanged |
| BVF INC/IL | $28.5M | 5.8M | Unchanged |
| FMR LLC | $27.8M | 5.7M | -5.6% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $21.4M | 4.4M | Unchanged |
| BlackRock, Inc. | $12.8M | 2.6M | +11.1% |
| RAYMOND JAMES FINANCIAL INC | $12.2M | 2.5M | -4.3% |
| Euclidean Capital LLC | $7.7M | 1.6M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.3M | 1.5M | 0% |
| GEODE CAPITAL MANAGEMENT, LLC | $4.4M | 910.9K | +7.4% |
| Siren, L.L.C. | $3.5M | 720.7K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.